Madrigal Pharmaceuticals (MDGL) Goodwill & Intangibles (2016 - 2026)
Madrigal Pharmaceuticals' (MDGL) quarterly Goodwill & Intangibles came in at $7.3 million in Q1 2026, up 57.02% year-on-year from $4.6 million in Q1 2025, and down 1.31% on a QoQ basis from $7.4 million in Q4 2025.
Madrigal Pharmaceuticals (MDGL) Goodwill & Intangibles (2016 - 2026) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has 4 years of Goodwill & Intangibles data on file, last reported at $7.3 million in Q1 2026.
- On a quarterly basis, Goodwill & Intangibles rose 57.02% year-over-year to $7.3 million in Q1 2026; TTM through Mar 2026 was $7.3 million, a 57.02% increase from a year earlier, with the FY2025 full-year figure at $7.4 million, up 56.08% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $7.3 million, down from $7.4 million in the prior quarter.
- Over the last five years, Goodwill & Intangibles for MDGL reached as high as $7.5 million in Q3 2025 and fell as low as $4.5 million in Q2 2025.
- Historically, Goodwill & Intangibles has averaged $5.6 million across 3 years, with a median of $4.9 million in 2024.
- Across the five-year window, Goodwill & Intangibles retreated 7.37% in 2025 and jumped 57.02% in 2026, its largest moves.
- Year by year, Goodwill & Intangibles stood at $4.7 million in 2024, then soared by 56.08% to $7.4 million in 2025, then declined by 1.31% to $7.3 million in 2026.
- Per Business Quant data, the three most recent Goodwill & Intangibles figures were $7.3 million in Q1 2026, $7.4 million in Q4 2025, and $7.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Madrigal Pharmaceuticals | 15.77 Bn | 15.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.28 Mn |
| Dec 31, 2025 | 7.38 Mn |
| Sep 30, 2025 | 7.48 Mn |
| Jun 30, 2025 | 4.55 Mn |
| Mar 31, 2025 | 4.64 Mn |
| Dec 31, 2024 | 4.73 Mn |
| Sep 30, 2024 | 4.82 Mn |
| Jun 30, 2024 | 4.91 Mn |
| Mar 31, 2024 | 5.00 Mn |
| Sep 30, 2016 | 315,070.00 |